期刊文献+

宫颈癌分段调强放射治疗计划的应用研究 被引量:9

The Applied Research of Phased Intensity-Modulated Radiotherapy for Cervical Cancer
下载PDF
导出
摘要 目的探讨宫颈癌患者分段调强放射治疗(IMRT)中的靶区体积及危及器官(OAR)的受照范围和剂量变化。方法 33例宫颈癌患者(FIGO分期Ⅰb~Ⅲb期)行调强放射治疗和同步化疗,放射治疗前和放射治疗3周(30 Gy)后行第二次CT及MRI扫描,重新制定调强治疗后半程计划,采用6MV X线,7野调强照射技术(7f-IMRT);处方剂量均为50.4 Gy/28 F。应用剂量体积直方图(dose-volume histogram,DVH)比较分析分段计划时靶区及危及器官体积及剂量变化。结果治疗前、后半程计划处方剂量均较好地覆盖了靶区。平均96.7%的PTV接受处方剂量的照射。PTV平均剂量(5024±65.8)cGy;(4993±111.5)cGy,差异无统计学意义。治疗前后肿瘤靶体积(GTV)分别为(77.39±36.82)cm3、(52.01±30.6)cm3,GTV体积退缩(30.1±8.9)%;临床靶体积(CTV)分别是303.2~718.9 cm3、301.3~630.7cm3,体积退缩(7.7±1.1)%,前后差异均有统计学意义(P<0.05)。小肠35 Gy的平均体积是(35.0±15.0)%、(31.0±12.2)%;小肠40 Gy的平均体积是(27.0±12.0)%、(24.0±11.0)%,差异均有统计学意义(P<0.05)。而直肠、膀胱40 Gy的平均体积分别是(71.0±13.0)%、(70.0±11.0)%;(74.0±11.0)%、(69.0±9.0)%,差异无统计学意义。结论宫颈癌患者采用调强适形放射治疗技术能够产生理想的靶区剂量分布,分段计划有助于提高靶区的适形度,减少正常组织受照射的体积和剂量。 Objective To evaluate the volumetric and the dosimetric change of target volumes and organs at risk( OARs) during the course of intensity-modulated radiation therapy( IMRT) for cervical cancer. Methods 33 cases of cervical cancer( stage ⅠB ~ ⅢB) treated by concurrent chemotherapy and IMRT were included. CT and MR images were acquired for each patient before treatment and at 30 Gy during treatment. All treatment plans were prescribed to deliver 50. 4 Gy to the planning tumor volume( PTV) for seven-field( 7f-IMRT) using 6MV X-Ray. The target volumes and OARs were contoured based on the fused CT-MRI images by comparing the original plan and the second plan. Results 2 plans were good prescribed dose covering the target area. 96. 7% of the PTV accept the prescribed dose on average. PTV average dose was( 5024 ± 65. 8) cGy;( 4993 ±111. 5) cGy respectively. The tumor volume shrunk on average( 30. 1 ± 8. 9) % of the initial volume after treatment,tumor target volume( GTV) were( 77. 39 ± 36. 82) cm3;( 52.01 ±30.6) cm3; CTV respectively was303.2 ~718.9 cm3;301.3 ~630.74 cm3,volume shrank( 7. 7 ± 1. 1) %. 35 Gy average volume of small intestine was( 35. 0 ± 15. 0) %;( 31. 0 ± 12. 2) %. Average volume of 40 Gy of small intestine was( 27. 0 ± 12. 0) %;( 24. 0 ± 11. 0) % respectively. The difference was significant. 40 Gy average volume of Rectum and bladder were( 71. 0 ± 13. 0) %;( 74. 0 ± 11. 0) % respectively and compared to( 70. 0 ± 11. 0) %;( 69.0 ±9.0) % respectively. There were no significant dosimetric differences in OARS. Conclusion Cervical cancer patients with intensity modulated radiotherapy technology can produce the ideal target area dose distribution,phased program helps to improve the target form degrees,reduce the volume of irradiated normal tissue and dose.
出处 《实用癌症杂志》 2014年第10期1253-1256,共4页 The Practical Journal of Cancer
基金 福建省卫生厅青年课题(编号:2012-1-7)
关键词 宫颈癌 放射治疗 调强技术 剂量体积直方图 辐射剂量 分段计划 Cervical cancer Radiotherapy IMRT DVH Radiation dosage Sectional plan
  • 相关文献

参考文献3

二级参考文献48

  • 1[1]Ahamad A,D'Souza W,Salehponr M,et al.Intensity -modulated radiation therapy after hysterectomy:Comparison with conventional treatment and sensitivity of tlle normal-tissue-sparing effect to margin size.Int J Radiat Oncol Biol Phys.2005.62:1117
  • 2[2]Ahmod RS,Kim BY,Duan J,Meleth S,et al.IMRT dose escalation for positive para-aortic lymph nodes in patients with locany advanced cervical cancer while reducing doseto bone marrow and other orgalls at risk.Int J Radiat Oncol Biol Phys.2004,60:505
  • 3[3]D'Souza WD,Ahamad AA,Iyer RB,et al.Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma.Int J Radiat Oncol Biol Phys,2005,61(4):1062
  • 4[4]Adli M,May NA,Kaiser HS,et al.Dose positioning reduce smail bowel dose in pelvic radiation with intensitvmodulated radiotherapy for gynecologic cancer?Int J Radiat Oncol Bid Phys,2003,57(1):230
  • 5[5]Portelance L,Chao KS,Grigsby PW,et al.Intensitymodulated radiation therapy (IMRT) reduces small bowel,rectum and bladder doses in patients with cervical cancer receiving pelvic and para-aortic inadiation.Int J Radiat Oncol Biol Phys,2001,51:261
  • 6[6]Taylor A,Rockall AG,Reznek RH,et al.Mapping Pelvic lymph nodes:Guidelines for delineation in intensitymodulated radiotherapy.Int J Radiat Oncol Bid Phys,2005,63(5):1604
  • 7Wolfson A H, Winter K, Crook W, et al. Are increased tumor aneuploidy and heightened cell proliferation along with heterogeneity associated with patient outcome for carcinomas of the uterine cervix? A combined analysis of subjects treated in RTOG 9001 and a single-institution trial[J] .Int J Radiat Oncol Biol Phys, 2008, 70(1):111-117.
  • 8Ahmed R S, Kim R Y, Duan J, et al. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk[J]. Int J Radiat Oneol Biol Phys, 2004, 60(2) :505- 512.
  • 9Mutic S, Malyapa R S, Grigsby P W, et al. PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study[J]. Int J Radiat Oncol Biol Phys, 2003, 55(1):28-35.
  • 10Tham I W, Lin S, Pan J, et al. Intensity-modulated radiation therapy without concurrent chemotherapy for stage II B nasopharyngeal cancer[J]. Am J Clin Oncol, 2010,33(3) :294-299.

共引文献69

同被引文献57

  • 1罗剑锋,刘美莲,冯凯华.肿瘤精确放疗技术的研究进展[J].世界临床医学,2017,11(21):87-88. 被引量:4
  • 2乌晓礼,王利华,索志敏,郁志龙.应用锥形束CT分析宫颈癌放射治疗中的摆位误差[J].内蒙古医科大学学报,2013,35(6):438-441. 被引量:4
  • 3李文彬,李明华,崔雪娥,William T.C.Yuh,Nina A.Mayr.MRI评价宫颈癌在放疗中形态和体积变化的临床意义[J].中国临床医学影像杂志,2004,15(7):391-395. 被引量:3
  • 4RENARD OLDRINI S,BRUNAUD C,HUGER S,et al.Dosime- tric comparison between the intensity modulated radiothempy with fixed field and Rapid Arc of cervix cancer[J].Cancer Radiother,2012,16(3):209-214.
  • 5MANT A J,LUJAN A E,ROTMENSCH J,et al.Intensity-modu- lated whole pelvic radiotherapy in women with gynecological malig- nancies[J].Int J Radiat Oncol Biol Phys,2002,52(5):1330-1337.
  • 6VAN DE BUNT L,VAN DER HEIDE U A,KETELAARS M,et al.Conventional,conformal,and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervi- cal cancer:The impact of tumor regression[J].Int J Radiat Oncol Biol Phys,2006,64(1):189-196.
  • 7TYAGI N,LEWIS J H,YASHAR C M,et al.Daily online cone beam computed tomography to assess interfractional motion in pa- tients with intact cervical cancer[J].Int J Radiat Oncol Biol Phys,2011,80(1):273-280.
  • 8NAM H,PARK W,HUH S J,et al.The prognostic significance of tumor volume regression during radiotherapy and concurrent che- moradiotherapy for cervical cancer using MRI[J].Gynecol Oncol,2007,107(2):320-325.
  • 9CHAN P,DINNIWELL R,HAIDER M A,et al.Inter and in- lrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy:a cinematic-MRI point-of-in- terest study[J].Int J Radiat Oncol Biol Phys,2009,73(1):235-241.
  • 10KERKHOF E M,RAAYMAKERS B W,VAN DER HEIDE U A,et al.Online MRI guidance for healthy tissue sparing in patients with cervical Cancer:an IMRT planning study[J].Radiother On- col,2008,88(2):241-249.

引证文献9

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部